Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.47 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.45 |
| ▸ | ABL1 | P00519 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28826635 | 0.91 | CYP1B1 (0.50) | BACE1TRPA1CYP1B1ALDH1A1HSD17B10 | |
| SCHEMBL29800497 | 0.91 | CYP1B1 (0.50) | BACE1TRPA1CYP1B1ALDH1A1HSD17B10 | |
| SCHEMBL31358639 | 0.87 | BACE1 (0.46) | BACE1TRPA1CYP1B1ALDH1A1HSD17B10 | |
| SCHEMBL28888937 | 0.85 | HPRT1 (0.52) | BACE1CYP1B1ALDH1A1HSD17B10CYP1A1 | |
| SCHEMBL25912390 | 0.84 | ALDH1A1 (0.48) | BACE1CYP1B1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL25912368 | 0.84 | HPRT1 (0.47) | BACE1CYP1B1ALDH1A1HSD17B10HIF1A | |
| SCHEMBL17414736 | 0.84 | BACE1 (0.59) | BACE1TRPA1CYP2A6ABL1ESR1 | |
| SCHEMBL31358636 | 0.84 | CYP1A2 (0.43) | BACE1TRPA1CYP1B1ALDH1A1HSD17B10 | |
| SCHEMBL26021734 | 0.83 | CYP2A6 (0.54) | BACE1TRPA1CYP1B1ALDH1A1HSD17B10 | |
| SCHEMBL25912566 | 0.83 | CYP1A2 (0.47) | BACE1CYP1B1ALDH1A1HSD17B10HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11696501-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-20230125420-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125420-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696501-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, AGO2, AOC2 | BACE1 821/4885TRPA1 138/4885CYP1B1 922/4885 |
| US-20230125420-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | OR51E2, NFE2L2, ETV6 | BACE1 1606/4885TRPA1 104/4885CYP1B1 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.